Journal News

Scientists find unexpected correlation between age and HDL-C levels

Jessica Desamero
June 3, 2025

Coronary heart disease, or CHD, is a type of heart disease in which coronary arteries can’t deliver enough oxygen-rich blood to the heart, causing chest pain, shortness of breath and potentially a heart attack. High-density lipoprotein cholesterol, or HDL-C, also known as “good” cholesterol, levels are a risk indicator of CHD. Naturally high HDL-C levels reduce the risk of CHD, while low HDL-C levels increase this risk.

In a recent Journal of Lipid Research study, researchers determined how various factors, such as age, physical activity and childbirth, predict HDL-C serum concentration in a large, diverse cohort of adults. This multicenter study is one of the few to analyze HDL-C over an extended period, over 30 years, rather than only one time point.

Scientific Animations

The Coronary Artery Risk Development in Young Adults study, or CARDIA, began in 1985 with a group of 5,115 Black and white men and women, aged 18–30 years, across multiple U.S. sites. James M. Shikany and his team led the coordinating center for the study at the University of Alabama at Birmingham. CARDIA examines the risk factors of CHD. Since then, Shikany has expanded the study to examine factors associated with HDL-C.

Participants receive tests and respond to questionnaires every five years to measure these factors. Shikany and his team then examine patterns in physical measurements, lifestyle factors, behavioral and psychological variables, medical and family history and blood concentrations of relevant substances. They then performed statistical regression analyses on the data. In their study, the team tested additional variables associated with HDL-C, including menopause status, hormone therapy and use of prescription drugs that lower cholesterol levels. Shikany said previous studies rarely examined these variables.

“I started noticing over the years that the HDL-C (serum levels) in CARDIA in men and women has been rising since year 15,” Shikany said. “(T)hat just piqued my interest.”

Shikany said this observation puzzled him because most participants showed higher weights, a characteristic usually associated with lower HDL-C levels.

The team observed that HDL-C levels positively correlated with age, alcohol intake, hormone therapy and birth control use and physical activity. Moreover, they found that individuals who had given birth had lower HDL-C levels than those who had not, with an even stronger correlation amongst those that birthed three or more children. Other factors associated with lower HDL-C concentrations include smoking and BMI.

Several questions remain, as the researchers did not identify one main factor driving the increased HDL-C levels. Shikany said age may be the driving factor, however, more research is needed to confirm that hypothesis.

Future directions will explore additional factors that may impact HDL-C levels and examine details of patient HDL-C, such as subtypes and functionality.

CARDIA is ongoing, and its duration will soon reach 40 years. Shikany said he hopes that the study will continue for many more years, allowing researchers to determine additional factors that influence cholesterol levels.

“We’ve always had very good retention; about 70% of the surviving cohorts come back for each exam,” Shikany said. “It’s really remarkable and shows their dedication, so we want to always express our appreciation.”

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Jessica Desamero

Jessica Desamero is a graduate of the biochemistry Ph.D. program at the City University of New York Graduate Center and an ASBMB volunteer contributor.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

When things get SAPpy: Novel insights into complement
Journal News

When things get SAPpy: Novel insights into complement

March 20, 2026

Researchers have defined interactions between an innate immune protein and two of its known binding partners. They identified potential areas of crosstalk between the two binding interactions.

Glutathione pathway implicated in rare disease
Journal News

Glutathione pathway implicated in rare disease

March 19, 2026

Researchers found that glutathione metabolism plays a central role in the pathogenesis of rare disease methylmalonic aciduria using a novel multiomics approach.

A p-value for proteins
Journal News

A p-value for proteins

March 18, 2026

Kyoto University researchers developed UniScore, a new tool that uses a target-decoy method to filter false positives in proteomic searches, helping scientists set thresholds and improve reliability when analyzing complex protein data.

Novel way to uncover tumor microenvironment proteomics
Journal News

Novel way to uncover tumor microenvironment proteomics

March 17, 2026

Researchers at the Weizmann Institute of Science developed a novel single-cell approach that facilitates the study of proteins surrounding lung cancer cells.

Sizing up cells: How stem cells know when to divide
News

Sizing up cells: How stem cells know when to divide

March 12, 2026

Stanford University researchers find that stem cells control their size early in cell division across living multicellular systems.

When oncogenes collide in brain development
Journal News

When oncogenes collide in brain development

March 10, 2026

Researchers at University Medical Center Hamburg, found that elevated oncoprotein levels within the Wnt pathway can disrupt the brain cell extracellular matrix, suggesting a new role for LIN28A in brain development.